vsar-8k_20170403.htm

0001564590-17-005893.txt : 20170403 0001564590-17-005893.hdr.sgml : 20170403 20170403113031 ACCESSION NUMBER: 0001564590-17-005893 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20170403 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170403 DATE AS OF CHANGE: 20170403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versartis, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 17732935 BUSINESS ADDRESS: STREET 1: 4200 BOHANNON DRIVE STREET 2: SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 6509638580 MAIL ADDRESS: STREET 1: 4200 BOHANNON DRIVE STREET 2: SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 8-K 1 vsar-8k_20170403.htm 8-K ENDO 2017 vsar-8k_20170403.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 3, 2017

Versartis, Inc.

(Exact name of registrant as specified in its charter)

Delaware	001-36361	26-4106690
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

4200 Bohannon Drive, Suite 250 Menlo Park, California		94025
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (650) 963-8580

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01

Other Events.

On April 3, 2017, the Company announced that new data on somavaratan in pediatric and adult GHD were presented during the Endocrine Society's 99th Annual Meeting & Expo (ENDO 2017), being held April 1-4, 2017 in Orlando, FL. A copy of the press release regarding this announcement, titled “Versartis Reports New Data on Long-Acting Somavaratan in Growth Hormone Deficiency at ENDO 2017” is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

In addition, on April 3, 2017, the Company announced that three-year safety and efficacy data on somavaratan in pediatric GHD were presented during an oral session at ENDO 2017, held April 1-4, 2017 in Orlando, FL. A copy of the press release regarding this announcement, titled “Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD” is attached as Exhibit 99.2 hereto and is incorporated herein by reference.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are furnished with this Current Report on Form 8-K.

Exhibit No.		Description
99.1		Press release dated April 3, 2017, titled “Versartis Reports New Data on Long-Acting Somavaratan in Growth Hormone Deficiency at ENDO 2017”
99.2		Press release dated April 3, 2017, titled “Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 3, 2017	VERSARTIS, INC. (Registrant)

	By:	/s/ Joshua T. Brumm
		Joshua T. Brumm
		Chief Financial Officer

INDEX TO EXHIBITS

Exhibit

No.

Description

99.1

Press release dated April 3, 2017, titled “Versartis Reports New Data on Long-Acting Somavaratan in Growth Hormone Deficiency at ENDO 2017”

99.2

Press release dated April 3, 2017, titled “Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD”

EX-99.1 2 vsar-ex991_6.htm EX-99.1 vsar-ex991_6.htm

EX_99.1

Versartis Reports New Data on Long-Acting Somavaratan in Growth Hormone Deficiency at ENDO 2017

•

Baseline characteristics of Phase 3 VELOCITY trial population balanced between study arms and comparable to Phase 2

•

Further results from the VITAL trial in adult GHD

•

Similar somavaratan PK/PD data in U.S. and Japanese children support using the same dose in the ongoing global and Japan Phase 3 trials

•

Conference call and webcast scheduled for 4:30 pm ET today featuring Versartis management and pediatric endocrinologist Bradley Miller, M.D., Ph.D.

MENLO PARK, Calif., April 3, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone (rhGH) for growth hormone deficiency (GHD), announced that new data on somavaratan in pediatric and adult GHD were presented during the Endocrine Society's 99th Annual Meeting & Expo (ENDO 2017), being held April 1-4, 2017 in Orlando, Florida. Somavaratan was featured in four posters and an oral session over the weekend and three-year safety and efficacy results from the ongoing VISTA pediatric long-term safety study are scheduled to be presented during an oral session today from 11:15-12:45 ET. The presentations will be made available at http://www.versartis.com/pipeline/publications/.

“As an investigator in the North American and European VELOCITY study, I was pleased to see that the stratification procedures that were applied to the trial have created consistency across the Phase 2 and Phase 3 patient populations, as well as balance between the two Phase 3 study arms,” said Philippe Backeljauw, M.D., Professor of Clinical Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children’s Hospital Medical Center. “These factors are important for the interpretation of the trial results, and the baseline characteristics in both studies reflect the type of GHD patient we treat in the United States. This provides essential context for endocrinologists reviewing the somavaratan Phase 3 data, which are anticipated this fall.”

“Unlike children, adults with GHD are more sensitive to therapy with GH, so identifying an appropriate dosing strategy for a new, long-acting form of GH is important for physicians who are going to treat these patients, either in the Phase 3 setting or in everyday clinical practice,” said Kevin C. J. Yuen, M.D., F.R.C.P., F.A.C.E., Medical Director, Swedish Pituitary Center at the Swedish Neuroscience Institute in Seattle. “In the Phase 2 VITAL trial, somavaratan was found to induce a robust IGF-I response in adults with GHD and these

findings have helped identify a twice-monthly dosing schedule and starting doses for titration that can be applied in the adult Phase 3 trial expected to start later this year.”

Pediatric GHD

POSTER PRESENTATION (31202): Achievement of a Suitable Basis of Comparison in Phase 2 and Phase 3 Pediatric Somavaratan Clinical Trials (VERTICAL, VISTA, and VELOCITY Studies) and for the Comparison of Somavaratan to Daily Recombinant Human Growth Hormone (rhGH)

Michael Stalvey, M.D., Assistant Professor and Physician, Fellowship Program Director, The University of Alabama at Birmingham, and colleagues compared the baseline characteristics of the 136 GHD children (104 randomized to twice-monthly somavaratan, 32 to daily rhGH) enrolled in the Phase 3 VELOCITY trial with those of the 64 GHD children who enrolled in the previously completed Phase 2a VERTICAL trial. The use of consistent inclusion/exclusion criteria in both trials and a stratification procedure to balance arms in the Phase 3 non-inferiority trial by region, expected median age, and expected median baseline IGF-I SDS has yielded similar treatment populations. No clinically meaningful differences exist between the somavaratan and daily rhGH arms of the Phase 3 VELOCITY trial or between the Phase 2 VERTICAL and Phase 3 VELOCITY trials. Thus, a valid basis of comparison between treatment populations has been achieved.

POSTER PRESENTATION (29268): IGF Family Biomarkers in the Diagnosis of Pediatric Growth Hormone Deficiency (PGHD) in Somavaratan Clinical Trials

George Bright, M.D., Global Pediatric Development Advisor for Versartis, and colleagues described an analysis of paired pretreatment IGF-I samples taken at screening and baseline from 196 subjects in the Phase 2a and Phase 3 trials of somavaratan in pediatric GHD to help determine within subject variability of IGF biomarkers in the study populations. Within-subject variability of IGF-I shows concordance of paired pretreatment IGF-I in the majority of pre-pubertal PGHD patients. However, concordance is adversely affected by selection of lower IGF-I SDS cutoff values, and differences in paired IGF-I samples tend to increase at lower IGF-I concentrations and at older ages. The treatment outcome predictive value of pretreatment IGF-I samples and within-subject variability is under study.

LATE-BREAKING POSTER PRESENTATION (33003): Pharmacokinetic and Pharmacodynamic (PK/PD) Analysis of Somavaratan (VRS-317), a Long-Acting Recombinant Human Growth Hormone (rhGH), in Japanese and US Children with Growth Hormone Deficiency (GHD)

Tomonobu Hasegawa, M.D., Professor of Pediatrics, Division of Endocrinology & Metabolism, Department of Pediatrics, Keio University School of Medicine, and colleagues described a comparison of the pharmacokinetic and pharmacodynamic (PK/PD) properties between pediatric subjects in the Phase 2 U.S. and Japanese studies of somavaratan. Given the effect of body weight on somavaratan PK parameters in both studies, the data continue to support weight-based dosing. After adjusting for differences in body weight, differences in exposure between Japanese and US populations did not merit changes in dosing principles. PD responses to somavaratan, including IGF-I SDS and IGFBP3, were comparable between the two study populations. The results of this analysis support the utilization of the same 3.5 mg/kg twice-monthly US Phase 3 dose in the ongoing Japanese Phase 3 trial.

Adult GHD

ORAL PRESENTATION (31263): Somavaratan, a Long-Acting Recombinant Human Growth Hormone (rhGH), for the Treatment of Adults with Growth Hormone Deficiency (AGHD): Results of VITAL, an Open-Label, Dose-Finding, International, Phase 2 Study (NCT02526420)

Dr. Yuen and colleagues summarized the results from VITAL, an open-label, international, multicenter, Phase 2 study evaluating safety, starting dose, and dose titration for monthly somavaratan administration in adults with GHD. Subjects were stratified into 3 cohorts (≥ 35 years of age, < 35 years of age, or female subjects on oral estrogen) with different starting doses based on expected requirements for rhGH. Somavaratan was well tolerated and induced a robust IGF-I response, with sustained effect for approximately 2 weeks. Following the last study dose, IGF-I SDS returned to pre-dose values by day 22. The study yielded information required to optimize somavaratan treatment in adults with GHD, including the starting dose, dosing frequency and titration plan. Lower starting doses of somavaratan administered twice monthly are now being investigated in the adult extension study and will be used in the Phase 3 trial expected to start later this year.

POSTER PRESENTATION (31432): Correlation Between Baseline IGF-I, Dose, and Response to Once-Monthly Somavaratan, a Long-Acting Recombinant Human Growth Hormone (rhGH), in the Open-Label, Dose-Finding, International, Phase 2 VITAL Study in Adults with Growth Hormone Deficiency (AGHD) (NCT02526420)

Martin Bidlingmaier, M.D., Head Endocrine Laboratory, Medizinische Klinik und Polklinik IV, Ludwig-Maximilians University, München, and colleagues described an analysis of data from the Phase 2 dose-finding VITAL study in AGHD to evaluate the relationships between baseline (BL) IGF-I levels and somavaratan dose and IGF-I response, and between BL IGF-I

and years since diagnosis of AGHD. Among adults with GHD, a clear distinction of IGF-I response to somavaratan and dose requirement based on BL IGF-I level was noted.

Conference Call/Webcast

The Versartis management team will host an ENDO review conference call and webcast today, April 3, 2017, at 4:30 pm ET, featuring Bradley S. Miller, M.D., Ph.D., Associate Professor in the Department of Pediatric Endocrinology at the University of Minnesota Masonic Children's Hospital. Dr. Miller is scheduled to present three-year data on somavaratan in pediatric GHD today at ENDO. The dial-in numbers are 877-407-0789 for domestic callers and 201-689-8562 for international callers. A live webcast of the conference call including a slide presentation will be available online from the investor relations page of the Company's corporate website at www.versartis.com.

After the live webcast, the call will remain available on the Versartis website, www.versartis.com, for 90 days. In addition, a telephonic replay of the call will be available until April 17, 2017. The replay dial-in numbers are 844-512-2921 for domestic callers and 412-317-6671 for international callers. Please use the replay conference ID number 13658330.

About Somavaratan

Somavaratan is Versartis' investigational, novel, long-acting form of recombinant human growth hormone (rhGH). This fusion protein consists of rhGH and specific sequences of hydrophilic amino acids based on a proprietary XTEN® technology¹. Somavaratan has been designed with the goal of improving therapeutic outcomes for children and adults with growth hormone deficiency (GHD), including enhanced adherence and convenience with a twice-monthly dosing schedule, fine gauge needle autoinjector device and room temperature storage.

Somavaratan is currently being evaluated for the treatment of pediatric GHD in the pivotal Phase 3 VELOCITY trial in the U.S., Canada and Europe, for which data are anticipated in September 2017, and the J14VR5 Phase 2/3 trial in Japan. Safety and efficacy data from 36 months of dosing in the Phase 2 trial and VISTA long-term safety study are scheduled to be presented during the Endocrine Society 2017 annual meeting. In adult GHD, results have been reported from the Phase 2 VITAL trial in the U.S., Europe and Australia and a Phase 3 trial is expected to begin by the end of 2017.

¹XTEN is a registered trademark of Amunix Operating Inc.

About Versartis, Inc.

Versartis, Inc. is an endocrine-focused biopharmaceutical company initially developing somavaratan, a novel, long-acting form of recombinant human growth hormone in late-stage clinical trials for the treatment of GHD in children and adults. Somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving adherence and, therefore, treatment outcomes.

For more information on Versartis, visit www.versartis.com.

Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding our intentions or current expectations concerning, among other things, plans and timing of our clinical trials and the potential for eventual regulatory approval of somavaratan. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks and uncertainties related to: our success being heavily dependent on somavaratan; somavaratan being a new molecular entity; the risk that somavaratan may not have favorable results in clinical trials or receive regulatory approval; potential delays in our clinical trials due to regulatory requirements or difficulty identifying qualified investigators or enrolling patients; the risk that somavaratan may cause serious side effects or have properties that delay or prevent regulatory approval or limit its commercial potential; the risk that we may encounter difficulties in manufacturing somavaratan; if somavaratan is approved, risks associated with its market acceptance, including pricing and reimbursement; potential difficulties enforcing our intellectual property rights; our reliance on our license of intellectual property from Amunix Operating, Inc. and our need for additional funds to support our operations. We discuss many of these risks in greater detail under the heading "Risk Factors" contained in our Annual Report on Form 10-K for the year ended December 31, 2016, which is on file with the Securities and Exchange Commission (SEC). Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward- looking statements whether as a result of new information, future events or otherwise, after the date of this press release.

Contacts:

Corporate Communications:

Christine Labaree

Corporate Affairs 

(650) 600-1697

clabaree@versartis.com

Investors: 

David Burke 

Director, Investor Relations

(650) 516-2703

dburke@versartis.com

EX-99.2 3 vsar-ex992_7.htm EX-99.2 vsar-ex992_7.htm

EX_99.2

Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD

▪	Mean height velocity during Years 1, 2, and 3 remained consistent and in line with U.S. daily rhGH treatment

▪	Height-SDS during the three-year treatment period continued to improve from baseline and was in line with U.S. registry data

▪	IGF-I responses achieved the target therapeutic range and were similar to U.S. registry data

MENLO PARK, Calif., April 3, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone (rhGH) for growth hormone deficiency (GHD), announced that three-year safety and efficacy data on somavaratan in pediatric GHD were presented during an oral session at the Endocrine Society's 99th Annual Meeting & Expo (ENDO 2017), held April 1-4, 2017 in Orlando, Florida. The presentation will be made available at http://www.versartis.com/pipeline/publications/.

“The analysis of somavaratan following three years of treatment experience has shown it to be performing in-line with daily rhGH data on key parameters, including height velocity, bone maturation and other key measures of catch-up growth, as well as IGF-I response, metabolic parameters, and safety,” said Bradley S. Miller, M.D., Ph.D., Associate Professor in the Department of Pediatric Endocrinology at the University of Minnesota Masonic Children's Hospital. “These results reinforce the 3.5 mg/kg twice-monthly dose selected for the ongoing Phase 3 VELOCITY trial, with mean peak IGF-I SDS at this dose in the upper half of the normal therapeutic range and no unexpected safety concerns. It is highly encouraging that the three-year results are in-line with results from U.S. registries, and this represents an incremental advancement of our knowledge of long-term treatment with somavaratan.”

“The Versartis team’s level of experience in the area of growth hormone is virtually unmatched, and we are all excited about the breadth and strength of our somavaratan data as we head into our pediatric Phase 3 results this fall,” said Jay Shepard, President and CEO of Versartis, Inc. “We believe that somavaratan has the potential to be best-in-class for treating children with GHD based on the profile that we are building. Our aim with somavaratan is to provide the convenience of twice monthly dosing without any ‘trade offs’ to daily rhGh therapy, and our three-year data have shown safety and efficacy that are comparable. At the time of our anticipated launch, we expect to have safety data

from up to five years of treatment as well as data on children who were switched from daily therapy, and we intend to price at parity. Our goal is to make somavaratan therapy an easy choice for physicians and their patients.”

Presentation Summary and Data

31135: Safety and Efficacy of Somavaratan (VRS-317), a Long-Acting Recombinant Human Growth Hormone (rhGH), in Children with Growth Hormone Deficiency (GHD): 3-Year Update of the VERTICAL & VISTA Trials (NCT01718041, NCT02068521)

The presentation by Dr. Miller summarized safety and efficacy data for the 48 patients who completed three years of somavaratan treatment in the Phase 2a VERTICAL study and subsequent VISTA long-term safety study. Overall, the three-year VERTICAL/VISTA study results support the selection of 3.5 mg/kg twice-monthly dose regimen for the Phase 3 VELOCITY trial underway. Mean height velocity during Years 1, 2, and 3 following dose increase at the beginning of Year 2 was consistent across three years of treatment and with reported HV for daily rhGH therapy in the U.S. (see Figure 1 below). Height-SDS for somavaratan during the three-year treatment period continued to improve from baseline and was in line with US registry data (Figure 2). Bone age versus chronologic age (Figure 3) were consistent with observed changes in U.S. registry studies. Furthermore, mean increase in bone age exceeded years on study, supporting catch-up growth. IGF-I responses with somavaratan achieved the target therapeutic range and were similar to those reported in U.S. registry data (Figure 4).

Treatment adherence to twice-monthly somavaratan was reported at 99.6% in patients receiving at-home dosing over a three-year period, whereas non-adherence to daily rhGH has been reported in up to 77% of GHD patients and is associated with reduced efficacy.

The safety profile remained consistent throughout three years of somavaratan treatment, with treatment-related adverse events that were generally mild and transient and no related serious adverse events. Metabolic parameters were normal and in line with daily rhGH.

About Somavaratan

Somavaratan is currently being evaluated for the treatment of pediatric GHD in the pivotal Phase 3 VELOCITY trial in the U.S., Canada and Europe, for which data are anticipated in September 2017, and the J14VR5 Phase 2/3 trial in Japan. Safety and efficacy data from 36 months of dosing in the Phase 2 trial and VISTA long-term safety study were presented during the Endocrine Society 2017 annual meeting. In adult GHD, results have been reported from the Phase 2 VITAL trial in the U.S., Europe and Australia and a Phase 3 trial is expected to begin by the end of 2017.

¹XTEN is a registered trademark of Amunix Operating Inc.

About Versartis, Inc.

For more information on Versartis, visit www.versartis.com.

Cautionary Note on Forward-Looking Statements

concerning, among other things, plans and timing of our clinical trials and the potential for eventual regulatory approval of somavaratan. Forward-looking statements are not

guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks and uncertainties related to: our success being heavily dependent on somavaratan; somavaratan being a new molecular entity; the risk that somavaratan may not have favorable results in clinical trials or receive regulatory approval; potential delays in our clinical trials due to regulatory requirements or difficulty identifying qualified investigators or enrolling patients; the risk that somavaratan may cause serious side effects or have properties that delay or prevent regulatory approval or limit its commercial potential; the risk that we may encounter difficulties in manufacturing somavaratan; if somavaratan is approved, risks associated with its market acceptance, including pricing and reimbursement; potential difficulties enforcing our intellectual property rights; our reliance on our license of intellectual property from Amunix Operating, Inc. and our need for additional funds to support our operations. We discuss many of these risks in greater detail under the heading "Risk Factors" contained in our Annual Report on Form 10-K for the year ended December 31, 2016, which is on file with the Securities and Exchange Commission (SEC). Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward- looking statements whether as a result of new information, future events or otherwise, after the date of this press release.

Contacts:

Corporate Communications:

Christine Labaree

Corporate Affairs 

(650) 600-1697

clabaree@versartis.com

Investors: 

David Burke 

Director, Investor Relations

(650) 516-2703

dburke@versartis.com

GRAPHIC 4 g20170403140609426621.jpg GRAPHIC begin 644 g20170403140609426621.jpg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end GRAPHIC 5 g20170403140609434622.jpg GRAPHIC begin 644 g20170403140609434622.jpg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end GRAPHIC 6 g20170403140609418620.jpg GRAPHIC begin 644 g20170403140609418620.jpg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end GRAPHIC 7 g20170403140609407619.jpg GRAPHIC begin 644 g20170403140609407619.jpg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end